Association study of BDNF and CNTF polymorphism to depression in non-demented subjects of the "VITA" study

被引:20
作者
Gruenblatt, E.
Hupp, E.
Bambula, M.
Zehetmayer, S.
Jungwirth, S.
Tragl, K. H.
Fischer, P.
Riederer, P.
机构
[1] Univ Wurzburg, Clin Psychiat & Psychotherapy, Natl Parkinson Fdn, Ctr Excellence Lab, D-97080 Wurzburg, Germany
[2] Ludwig Boltzmann Inst Aging Res, Ludwig Boltzmann Soc, Vienna, Austria
[3] Med Univ Vienna, Inst Med Stat, Vienna, Austria
[4] Univ Hosp Psychiat, Dept Gen Psychiat, Vienna, Austria
关键词
BDNF; CNTF; depression; diagnostic tools; neurotrophic; polymorphism;
D O I
10.1016/j.jad.2006.05.008
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Neurotrophic factors are known to play an important role in the survival and differentiation of many types of neurons during development. Both brain-derived neurotrophic factor (BDNF) and ciliary neurotrophic factor (CNTF) may act cooperatively in modulating the development and functioning of synapses. Both these neurotrophic factors were intensely investigated with regard to depression without conclusive results. Methods: We have investigated the possible use of both CNTF null-mutation and BDNF polymorphism C270T as biomarkers for depression in the Vienna Transdanube Aging (VITA) study. The VITA is a prospective community-based cohort study of all 75 years old inhabitants of a geographical region of Vienna. Results: We found no association between CNTF null-mutation and BDNF C270T polymorphism to any depressive symptoms after exclusion of demented subjects. Conclusion: These results call in question the hypothesis that either BDNF or CNTF can be used as molecular markers for depression or late onset depression in the elderly. (c) 2006 Elsevier B.V. All rights reserved.
引用
收藏
页码:111 / 116
页数:6
相关论文
共 41 条
[1]   BDNF in schizophrenia, depression and corresponding animal models [J].
Angelucci, F ;
Brenè, S ;
Mathé, AA .
MOLECULAR PSYCHIATRY, 2005, 10 (04) :345-352
[2]  
ARAKAWA Y, 1990, J NEUROSCI, V10, P3507
[3]   Brain-derived neurotrophic factor genetic variants are not susceptibility factors to Alzheimer's disease in Italy [J].
Bagnoli, S ;
Nacmias, B ;
Tedde, A ;
Guarnieri, BM ;
Cellini, E ;
Petruzzi, C ;
Bartoli, A ;
Ortenzi, L ;
Sorbi, S .
ANNALS OF NEUROLOGY, 2004, 55 (03) :447-448
[4]   Plasma amyloid β protein 42 in non-demented persons aged 75 years:: Effects of concomitant medication and medial temporal lobe atrophy [J].
Blasko, I ;
Kemmler, G ;
Krampla, W ;
Jungwirth, S ;
Wichart, I ;
Jellinger, K ;
Tragl, KH ;
Fischer, P .
NEUROBIOLOGY OF AGING, 2005, 26 (08) :1135-1143
[5]   Increased hippocampal BDNF immunoreactivity in subjects treated with antidepressant medication [J].
Chen, B ;
Dowlatshahi, D ;
MacQueen, GM ;
Wang, JF ;
Young, LT .
BIOLOGICAL PSYCHIATRY, 2001, 50 (04) :260-265
[6]   Investigation of the effect of brain-derived neurotrophic factor (BDNF) polymorphisms on the risk of late-onset Alzheimer's disease (AD) and quantitative measures of AD progression [J].
Desai, P ;
Nebes, R ;
DeKosky, ST ;
Kamboh, MI .
NEUROSCIENCE LETTERS, 2005, 379 (03) :229-234
[7]   Role of neurotrophic factors in the etiology and treatment of mood disorders [J].
Duman, RS .
NEUROMOLECULAR MEDICINE, 2004, 5 (01) :11-25
[8]   Reduced activation and expression of ERK1/2 MAP kinase in the post-mortem brain of depressed suicide subjects [J].
Dwivedi, Y ;
Rizavi, HS ;
Roberts, RC ;
Conley, RC ;
Tamminga, CA ;
Pandey, GN .
JOURNAL OF NEUROCHEMISTRY, 2001, 77 (03) :916-928
[9]   Altered gene expression of brain-derived neurotrophic factor and receptor tyrosine kinase B in postmortem brain of suicide subjects [J].
Dwivedi, Y ;
Rizavi, HS ;
Conley, RR ;
Roberts, RC ;
Tamminga, CA ;
Pandey, GN .
ARCHIVES OF GENERAL PSYCHIATRY, 2003, 60 (08) :804-815
[10]  
Elashoff J.D., 2000, nQuery Advisor Version 4.0 User's Guide